Stem cells and oxygen therapy may save hips from collapse
NCT ID NCT07560163
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a triple therapy—surgery, stem cells, and hyperbaric oxygen—in 24 patients with early-stage osteonecrosis (bone death) of the hip. After two years, patients reported better hip function and fewer needed a hip replacement. The approach aims to stop the bone from collapsing and avoid major surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stromal vascular fraction (stem cells)
- What this could lead to
- If this triple therapy works, it could offer a way to treat early hip bone death without needing a hip replacement.
- What could go wrong
- This is a small, retrospective study with no comparison group, so results may not apply to everyone. The treatment is complex and not yet proven in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEONECROSIS OF THE FEMORAL HEAD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could catch hip disease before It's too late
- New drug RAB001 takes first step: safety check in healthy volunteers
- New combo treatment aims to save hips from collapse
- New drug aims to stop hip bone death from steroids
- Could your own bone marrow cells save your hip from collapse?
- New combo nerve block may ease hip surgery pain better